COVID-19 is more lethal in hemodialysis chronic kidney disease patients with low physical capacity

被引:2
|
作者
Orcy, Rafael B. [1 ,2 ,6 ]
Bluhm, Caroline C. [1 ]
Ribeiro, Larissa R. [3 ]
Sosa, Priscila M. [4 ]
Correa, Bianca D. [4 ]
Barcellos, Franklin C. [5 ]
Bohlke, Maristela [3 ,5 ]
机构
[1] Univ Fed Pelotas, Postgrad Programme Phys Educ, Pelotas, Brazil
[2] Fed Univ Pelota, Multictr Postgrad Programme Physiol Sci, Pelotas, Brazil
[3] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil
[4] Univ Fed Pelotas, Higher Sch Phys Educ & Physiotherapy, Pelotas, Brazil
[5] Sao Francisco Paula Univ Hosp, Dialysis & Kidney Transplantat Unit, Pelotas, Brazil
[6] 625 Luis Camoes St, BR-96055630 Pelotas, Brazil
关键词
COVID-19; functional capacity; hemodialysis patients; 6-MINUTE WALK TEST; OLDER-ADULTS; MORTALITY; STRENGTH; SURVIVAL; DISTANCE;
D O I
10.1111/1744-9987.14069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The mortality rate in patients on maintenance hemodialysis (HD) is high and is associated with low functional capacity (FC). We analyzed the association of FC and COVID-19 lethality among HD patients. Methods: A cohort study that included evaluations of FC in patients on HD was underway, and the association between FC and lethality was included as an ad-hoc outcome. Results: One hundred and twelve patients were submitted to a physical, 31 patients contracted symptomatic COVID-19, 20 recovered and 11 died (lethality rate of 35.5%). There was a difference between survivors and non-survivors on six-minutes-walking-test (6MWT) 386.1 +/- 112.8 versus 296.9 +/- 103.3 meters (p = 0.04), 30 s sit-to-stand test (30CST) score 11.7 +/- 3.1 versus 7.7 +/- 4.1 (p = 0.006), and timed up and go test (TUG) 9.4 versus 13.6 s (p = 0.009). There was also an association between percentages of predicted 6MWT, 30CST, and TUG with COVID-19 lethality. Conclusion: Patients on maintenance HD with poorer physical performance presented the worst prognosis from COVID-19 pandemic.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [31] Chronic kidney disease and hypertension with reference to COVID-19
    Rathi, Manish
    Jeloka, Tarun
    Prasad, Narayan
    Bansal, Shyam
    Agarwal, Sanjay Kumar
    Bhalla, A. K.
    INDIAN JOURNAL OF NEPHROLOGY, 2020, 30 (03) : 155 - 157
  • [32] COVID-19 and chronic kidney disease: a comprehensive review
    Pecly, Inah Maria D.
    Azevedo, Rafael B.
    Muxfeldt, Elizabeth S.
    Botelho, Bruna G.
    Albuquerque, Gabriela G.
    Diniz, Pedro Henrique P.
    Silva, Rodrigo
    Rodrigues, Cibele I. S.
    JORNAL BRASILEIRO DE NEFROLOGIA, 2021, 43 (03): : 383 - 399
  • [33] Prevention and Control of COVID-19 in Chronic Kidney Disease
    Shipin Feng
    Min Xie
    Wei Luo
    Li Wang
    Limin Guo
    Ying Wu
    Jun Liu
    Qinwei Duan
    Qin Yang
    Jia Li
    Xi Liu
    Rong Zhu
    The Indian Journal of Pediatrics, 2020, 87 : 550 - 551
  • [34] COVID-19 and Chronic Kidney Disease: A Narrative Review
    Martins, Marilia Paiva
    de Oliveira, Rodrigo Bueno
    COVID, 2023, 3 (08): : 1092 - 1105
  • [35] COVID-19 and Nutrition: Focus on Chronic Kidney Disease
    Mafra, Denise
    Kemp, Julie A.
    Cardozo, Ludmila F. M. F.
    Borges, Natalia A.
    Nerbass, Fabiana B.
    Alvarenga, Livia
    Kalantar-Zadeh, Kamyar
    JOURNAL OF RENAL NUTRITION, 2023, 33 (06) : S118 - S127
  • [36] COVID-19 quarantine in chronic kidney disease patients: A focus on sarcopenia traits
    Ribeiro, Heitor Siqueira
    Wilund, Kenneth R.
    Lima, Ricardo Moreno
    JORNAL BRASILEIRO DE NEFROLOGIA, 2021, 43 (02): : 293 - 294
  • [37] COVID-19 in Grade 4-5 Chronic Kidney Disease Patients
    Collado, Silvia
    Arenas, Maria Dolores
    Barbosa, Francesc
    Cao, Higini
    Montero, Maria Milagro
    Villar-Garcia, Judit
    Barrios, Clara
    Rodriguez, Eva
    Sans, Laia
    Sierra, Adriana
    Perez-Saez, Maria Jose
    Redondo-Pachon, Dolores
    Coca, Armando
    Maiques, Jose Maria
    Gueerri-Fernandez, Roberto
    Horcajada, Juan Pablo
    Crespo, Marta
    Pascual, Julio
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (05): : 768 - 774
  • [38] The impact of COVID-19 on right ventricular function in chronic kidney disease patients
    Tapoi, L.
    Ureche, C.
    Diaconu, A.
    Vasiliu, V.
    Siriteanu, L.
    Andrian, T.
    Stefan, A.
    Baluta, C.
    Apetrii, M.
    Dodi, G.
    Nistor, I.
    Onofriescu, M.
    Sascau, R.
    Statescu, C.
    Covic, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 63 - 63
  • [39] How to use COVID-19 antiviral drugs in patients with chronic kidney disease
    Kale, Ajinath
    Shelke, Vishwadeep
    Dagar, Neha
    Anders, Hans-Joachim
    Gaikwad, Anil Bhanudas
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease
    Lafont, Emmanuel
    Blez, Damien
    Bildan, Marc-Antoine
    Veyer, David
    Pere, Helene
    Puech, Julien
    Kably, Benjamin
    Cheminet, Geoffrey
    Pouchot, Jacques
    Thervet, Eric
    Peytavin, Gilles
    Lazareth, Helene
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (03) : 798 - 800